MOLECULAR BIOLOGY OF SCHISTOSOME-SNAIL INTERACTIONS
Project Number5R01AI023700-05
Contact PI/Project LeaderGRANATH, WILLARD O
Awardee OrganizationUNIVERSITY OF MONTANA
Description
Abstract Text
The overall objective of this research is to elucidate the molecular,
biochemical and cellular events responsible for determining susceptibility
or resistance of the snail, Biomphalaria glabrata, to infection with the
human blood fluke, Schistosoma mansoni. The system used consists of the
NIH-Sm-PR-1 strain of S. mansoni, to which PR albino, M-line B. glabrata
are susceptible, and the pigmented 10-R2 and the albino 13-16-R1 strains
which are actively resistant to the parasite. There are three major goals
of this proposal:
1. During the past grant period a 55 kDa polypeptide in the serum of 10-R2
B. glabrata that binds to S. mansoni sporocysts was discovered.
Interestingly, similar molecular weight proteins from M-line serum did not
bind to the parasite. Therefore, the structure and function of serum
polypeptides (from the three snail strains) will be characterized using
electrophoretic and peptide mapping techniques. Antibodies to these
polypeptides will be generated, and immunofluorescent antibody tests (IFAT)
and immunoscanning electron microscopy (ISEM) will be used to assess their
binding properties. Lastly, these reagents will be used in important
functional analysis experiments using several in vitro and in vivo systems.
2. During the past grant period an 80 kDa surface-polypeptide unique to
hemocytes from resistant B. glabrata was identified. Such a polypeptide
may play a crucial role in mediating larval schistosome destruction.
Therefore, hemocytes will be thoroughly characterized by surface-labeling,
electrophoretic and peptide mapping techniques. Next, antibodies to the
major surface proteins will be generated, and IFAT and ISEM will be used to
determine their binding characteristics. Furthermore, these reagents will
be used in a variety of important functional analysis experiments.
3. Since the mechanism by which hemocytes respond to schistosome infection
is unknown, hemocyte formation in B. glabrata will be studied by following
the fate of injected thymidine-14C. Hemocyte activation will be examined
by measuring RNA and protein synthesis using radioactive precursors.
Finally, surface characteristics of activated hemocytes, and the functional
relevance of these cells will be evaluated using several in vitro systems.
This research will make a significant contribution to the understanding of
how vector competence is manifested in schistosome-snail interactions,
which will be useful in designing rational vector control programs.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
010379790
UEI
DAY7Z8ZD48Q3
Project Start Date
01-July-1987
Project End Date
28-February-1995
Budget Start Date
01-March-1992
Budget End Date
28-February-1993
Project Funding Information for 1992
Total Funding
$156,238
Direct Costs
$115,022
Indirect Costs
$41,216
Year
Funding IC
FY Total Cost by IC
1992
National Institute of Allergy and Infectious Diseases
$156,238
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI023700-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI023700-05
Patents
No Patents information available for 5R01AI023700-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI023700-05
Clinical Studies
No Clinical Studies information available for 5R01AI023700-05
News and More
Related News Releases
No news release information available for 5R01AI023700-05
History
No Historical information available for 5R01AI023700-05
Similar Projects
No Similar Projects information available for 5R01AI023700-05